CELG.RI

Bristol Myers Squibb Co.

NYSEAdd to watchlist

$0.12

+$0.02+20.16%

Delayed · 2026-08-25T20:00:00.000Z · marketstack

3 open-market sales on file ($2.29M), none of them under a pre-arranged plan. Who, and when

Aug 24, 2026$0.12

+$0.02+20.16%over 1M

Session

Day range99% of range

$0.09$0.12

Fundamentals

Visualize fundamentals and more

Market cap: 244.63M
P/E ratio: 0.03

Recent activity

Sep 9 Massacesi Cristian sold 6,249 shares Insider trading Form 4 EVP,Chief Med Offr,Head of Dev, about $403k
Apr 1 Elkins David V sold 30,000 shares Insider trading Form 4 EVP, Chief Financial Officer, about $1.9M

2 more events are on Measure

Measure Create a free account

Free, no card, and it does not expire. See what the paid plans add

Discussion

No comments yet

Set a username to join the discussion. It’s the only thing shown next to what you post, never your email address.

Comments are written by other users. Nothing here is investment advice and nothing is checked for accuracy.

Updated Aug 25, 2026 · the last close

Bristol Myers Squibb Co. investor relations

What CELG.RI has filed with the SEC. This is not Bristol Myers Squibb Co.’s own investor relations site: these filings are the primary source that site publishes from.

Where else CELG.RI appears

CELG.RI is among the largest companies matching:

Ask about Bristol Myers Squibb Co.

The assistant answers from what CELG.RI has actually filed: 19 annual reports filed with the SEC and 129 Form 4 filings from the last year. Every figure in a reply links to the filing it came from, so an answer can be checked rather than believed.

Press one and the answer appears right here on the page, from CELG.RI's filings and figures. One a day without an account; a free account has its own, and no card.

What an account lets you do with Bristol Myers Squibb Co.

Be told the moment a CELG.RI insider trades
Put Bristol Myers Squibb Co. on a watchlist for a free alert, the bell and a daily email, when a Form 4 worth a row is filed, with vesting and automatic tax sales already struck out so what lands is a decision, not paperwork.
The full filing historyMeasure
Ask what growth the price is already betting on
Bristol Myers Squibb Co.'s income statement, balance sheet and cash flow as filed, and the ratios computed from them, plus a reverse DCF that holds today's price fixed and solves for the growth it requires.
The reverse DCFMeasure
Watch the same stakes the professionals are watching
Every tracked position priced at the quarter it was filed and diffed against the one before it: how big a bet each one is, and by how much it changed.
Every position, sizedMeasure
Interrogate the filing, not the internet
Ask anything about Bristol Myers Squibb Co.'s fundamentals. The assistant answers from its own filings and cites the figure, never a guess from the open web.

Create a free account See what the paid plans add

Free, no card, and it does not expire.